Investigating trait variability of gene co-expression network architecture in brain by controlling for genomic risk of schizophrenia.

Bibliographic Details
Title: Investigating trait variability of gene co-expression network architecture in brain by controlling for genomic risk of schizophrenia.
Authors: Eugenia Radulescu, Qiang Chen, Giulio Pergola, Pasquale Di Carlo, Shizhong Han, Joo Heon Shin, Thomas M Hyde, Joel E Kleinman, Daniel R Weinberger
Source: PLoS Genetics, Vol 19, Iss 10, p e1010989 (2023)
Publisher Information: Public Library of Science (PLoS), 2023.
Publication Year: 2023
Collection: LCC:Genetics
Subject Terms: Genetics, QH426-470
More Details: The effect of schizophrenia (SCZ) genetic risk on gene expression in brain remains elusive. A popular approach to this problem has been the application of gene co-expression network algorithms (e.g., WGCNA). To improve reliability with this method it is critical to remove unwanted sources of variance while also preserving biological signals of interest. In this WCGNA study of RNA-Seq data from postmortem prefrontal cortex (78 neurotypical donors, EUR ancestry), we tested the effects of SCZ genetic risk on co-expression networks. Specifically, we implemented a novel design in which gene expression was adjusted by linear regression models to preserve or remove variance explained by biological signal of interest (GWAS genomic scores for SCZ risk-(GS-SCZ), and genomic scores- GS of height (GS-Ht) as a negative control), while removing variance explained by covariates of non-interest. We calculated co-expression networks from adjusted expression (GS-SCZ and GS-Ht preserved or removed), and consensus between them (representative of a "background" network free of genomic scores effects). We then tested the overlap between GS-SCZ preserved modules and background networks reasoning that modules with reduced overlap would be most affected by GS-SCZ biology. Additionally, we tested these modules for convergence of SCZ risk (i.e., enrichment in PGC3 SCZ GWAS priority genes, enrichment in SCZ risk heritability and relevant biological ontologies. Our results highlight key aspects of GS-SCZ effects on brain co-expression networks, specifically: 1) preserving/removing SCZ genetic risk alters the co-expression modules; 2) biological pathways enriched in modules affected by GS-SCZ implicate processes of transcription, translation and metabolism that converge to influence synaptic transmission; 3) priority PGC3 SCZ GWAS genes and SCZ risk heritability are enriched in modules associated with GS-SCZ effects. Overall, our results indicate that gene co-expression networks that selectively integrate information about genetic risk can reveal novel combinations of biological pathways involved in schizophrenia.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1553-7390
1553-7404
Relation: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1010989&type=printable; https://doaj.org/toc/1553-7390; https://doaj.org/toc/1553-7404
DOI: 10.1371/journal.pgen.1010989&type=printable
DOI: 10.1371/journal.pgen.1010989
Access URL: https://doaj.org/article/5b4e1686789a4b1b9371751ae2a7254d
Accession Number: edsdoj.5b4e1686789a4b1b9371751ae2a7254d
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:15537390
15537404
DOI:10.1371/journal.pgen.1010989&type=printable
Published in:PLoS Genetics
Language:English